We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Uric Acid in Saliva Is a Biomarker for Body Fat Accumulation in Adolescents

By LabMedica International staff writers
Posted on 24 Feb 2020
Print article
Image: The level of uric acid in saliva is a good indicator of body fat percentage in a study designed to identify reliable biomarkers that can be used to develop quick non-invasive tests for early detection of chronic diseases ((Photo courtesy of Dr. Paula Midori Castelo, Federal University of São Paulo)
Image: The level of uric acid in saliva is a good indicator of body fat percentage in a study designed to identify reliable biomarkers that can be used to develop quick non-invasive tests for early detection of chronic diseases ((Photo courtesy of Dr. Paula Midori Castelo, Federal University of São Paulo)
The noninvasive measurement of uric acid in saliva has been shown to be an important marker of body fat accumulation in adolescents, which demonstrates the clinical relevance of saliva for detection of early metabolic changes and monitoring of nutritional status.

Uric acid is the end-product of the metabolic breakdown of purines, which are nitrogenous bases in DNA and RNA. It accumulates in the blood and, at much lower concentrations, in the saliva. Although uric acid acts as an antioxidant, when levels become too high in the blood and saliva owing to dysregulated purine degradation, it can lead to a predisposition to develop hypertension, inflammation, and cardiovascular disease.

Investigators at the Federal University of São Paulo (Brazil) and the University of Campinas (Brazil) hypothesized that saliva could provide reliable markers – such as uric acid – able to predict accumulation of body fat in young subjects.

To test this theory, the investigators determined the salivary characteristics of 248 adolescent students (119 girls, 129 boys; 14-17 years of age). Potential participants in the study underwent oral examination to identify those with cavities and/or periodontal disease. Such subjects were excluded from the study, since cavities and periodontal disease are known to influence salivary parameters such as pH, electrolytic composition, and biochemistry. Physical examination of the subjects included height, weight, and body fat percentage (%BF) measured using bioelectric impedance to classify groups as being below or above the %BF cutoff level.

Saliva samples collected at home following a 12-hour fast were assayed by high-performance liquid chromatography (HPLC) for levels of uric acid, cholesterol, 7-ketocholesterol, and 25-hydroxyvitamin D2 and D3 and other metabolites.

Results revealed no significant difference in the levels of 25-hydroxyvitamin D2 and D3, cholesterol, 7-ketocholesterol, phosphorus, calcium, and urea between groups above and below the %BF cutoff, and the variation in salivary flow was small. In contrast, significant gender and group effects were observed for salivary uric acid, which was increased in adolescents with higher %BF and in males (compared to females). Gender showed a significant effect on salivary urea, with lower levels in females.

"The idea is to enable saliva to be more widely used as an alternative biological sample for clinical analysis. The advantage of saliva is that it can be collected several times noninvasively and painlessly, like urine. The study showed the level of salivary uric acid to be a good predictor of body fat percentage even in adolescents considered healthy," said senior author Dr. Paula Midori Castelo, associate professor of biological sciences at the Federal University of São Paulo.

The salivary uric acid study was published in the February 2020 issue of the journal Nutrition Research.

Related Links:
Federal University of São Paulo
University of Campinas


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.